Lancet. 2019 Mar 20. pii: S0140-6736(19)30024-8. doi: 10.1016/S0140-6736(19)30024-8. [Epub ahead of print]

Building a tuberculosis-free world: The Lancet Commission on tuberculosis.

Reid MJA1, Arinaminpathy N2, Bloom A3, Bloom BR4, Boehme C5, Chaisson R6, Chin DP7, Churchyard G8, Cox H9, Ditiu L10, Dybul M11, Farrar J12, Fauci AS13, Fekadu E14, Fujiwara PI15, Hallett TB2, Hanson CL7, Harrington M16, Herbert N17, Hopewell PC18, Ikeda C19, Jamison DT20, Khan AJ21, Koek I22, Krishnan N23, Motsoaledi A24, Pai M25, Raviglione MC26, Sharman A27, Small PM28, Swaminathan S29, Temesgen Z30, Vassall A31, Venkatesan N32, van Weezenbeek K33, Yamey G34, Agins BD35, Alexandru S36, Andrews JR37, Beyeler N38, Bivol S39, Brigden G15, Cattamanchi A18, Cazabon D40, Crudu V39, Daftary A25, Dewan P41, Doepel LK13, Eisinger RW13, Fan V42, Fewer S38, Furin J43, Goldhaber-Fiebert JD44, Gomez GB45, Graham SM46, Gupta D47, Kamene M48, Khaparde S49, Mailu EW48, Masini EO50, McHugh L51, Mitchell E52, Moon S53, Osberg M54, Pande T40, Prince L44, Rade K55, Rao R56, Remme M57, Seddon JA58, Selwyn C7, Shete P18, Sachdeva KS47, Stallworthy G59, Vesga JF2, Vilc V60, Goosby EP61.

Author information

1

Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA. Electronic address: michael.reid2@ucsf.edu.

2

School of Public Health, Imperial College London, London, UK; Faculty of Medicine, Imperial College London, London, UK.

3

Tuberculosis Division, United States Agency for International Development, Washington, DC, USA.

4

Department of Global Health and Population, Harvard University, Cambridge, MA, USA.

5

Foundation for Innovative New Diagnostics, Geneva, Switzerland.

6

Departments of Medicine, Epidemiology, and International Health, Johns Hopkins School of Medicine, Baltimore, MA, USA.

7

Bill & Melinda Gates Foundation, Seattle, WA, USA.

8

The Aurum Institute, Johannesburg, South Africa.

9

Department of Pathology, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

10

Stop TB Partnership, Geneva, Switzerland.

11

Department of Medicine, Centre for Global Health and Quality, Georgetown University, Washington, DC, USA.

12

The Wellcome Trust, London, UK.

13

National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Maryland, MA, USA.

14

Volunteer Health Services, Addis Ababa, Ethiopia.

15

Department of Tuberculosis and HIV, The International Union Against Tuberculosis and Lung Disease, Paris, France.

16

Treatment Action Group, New York, NY, USA.

17

Global TB Caucus, Houses of Parliament, London, UK.

18

Department of Medicine, University of California San Francisco, San Francisco, CA, USA.

19

Department of GLobal Health, Ministry of Heath, Labor and Welfare, Tokyo, Japan.

20

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.

21

Interactive Research & Development, Karachi, Pakistan.

22

Global Health Bureau, United States Agency for International Development, Washington, DC, USA.

23

Resource Group for Education and Advocacy for Community Health, Chennai, India.

24

South African National Department of Health, Pretoria, South Africa.

25

Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada; McGill International TB Center, McGill University, Montreal, QC, Canada.

26

University of Milan, Milan, Italy; Global Studies Institute, University of Geneva, Geneva, Switzerland.

27

Academy of Preventive Medicine of Kazakhstan, Almaty, Kazakhstan.

28

Global Health Institute, School of Medicine, Stony Brook University, Stony Brook, NY, USA.

29

WHO, Geneva, Switzerland.

30

Department of Infectious Diseases, Mayo Clinic, Rochester, MI, USA.

31

Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK; Amsterdam Institute for Global Health and Development, University of Amsterdam, Amsterdam, Netherlands.

32

The Economic Times, Mumbai, India.

33

KNCV Tuberculosis Foundation, The Haag, Netherlands.

34

Center for Policy Impact in Global Health, Duke Global Health Institute, Duke University, Durham, NC, USA.

35

Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.

36

Institutul de Ftiziopneumologie Chiril Draganiuc, Chisinau, Moldova.

37

Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA.

38

Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.

39

Center for Health Policies and Studies, Chisinau, Moldova.

40

McGill International TB Center, McGill University, Montreal, QC, Canada.

41

Bill & Melinda Gates Foundation, New Delhi, India.

42

T H Chan School of Public Health, Harvard University, Cambridge, MA, USA; Office of Public Health Studies, University of Hawaii, Mānoa, HI, USA.

43

Division of Infectious Diseases & HIV Medicine, Case Western Reserve University, Cleveland, OH, USA.

44

Centers for Health Policy and Primary Care and Outcomes Research, Stanford University, Stanford, CA, USA.

45

Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.

46

Department of Tuberculosis and HIV, The International Union Against Tuberculosis and Lung Disease, Paris, France; Department of Paediatrics, Center for International Child Health, University of Melbourne, Melbourne, VIC, Australia; Burnet Institute, Melbourne, VIC, Australia.

47

Revised National TB Control Program, New Delhi, India.

48

National Tuberculosis, Leprosy and Lung Disease Program, Ministry of Health, Nairobi, Kenya.

49

General TB control, New Delhi, India.

50

WHO, Nairobi, Kenya.

51

Office of the Secretary-General's Special Envoy on Tuberculosis, United Nations, Geneva, Switzerland.

52

International Institute of Social Studies, Erasmus University Rotterdam, The Hague, Netherland.

53

Department of Global Health and Population, Harvard University, Cambridge, MA, USA; Global Health Centre, The Graduate Institute Geneva, Geneva, Switzerland.

54

Linksbridge, Seattle, WA, USA.

55

Central Tuberculosis Division, WHO, New Delhi, India.

56

Ministry of Health and Family Welfare, New Delhi, India.

57

International Institute for Global Health, United Nations University, Kuala Lumpur, Malaysia.

58

Department of Medicine, Imperial College London, London, UK; Faculty of Medicine, Imperial College London, London, UK; Department of Paediatrics and Child Health, Stellenbosch University, Stellenbosch, South Africa.

59

Seattle, WA, USA.

60

National TB Program, WHO, Chisinau, Moldova.

61

Department of Medicine, University of California San Francisco, San Francisco, CA, USA; Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA.